A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 7620752.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A study was conducted to validate a comprehensive self-rating scale for measuring side-effects of neuroleptic drugs. The Liverpool University Neuroleptic Side Effect Rating Scale (LUNSERS), which includes 'red herring' items, was twice administered to 50 DSM-III-R schizophrenic patients, who were also interviewed using the UKU side-effect rating scale; 50 unmedicated controls also completed the LUNSERS: The test-retest reliability of the LUNSERS was good (r = 0.811, P < 0.001) as was its concurrent validity against the UKU (r = 0.828, P < 0.001). Scores correlated with chlorpromazine equivalent doses (r = 0.310, P < 0.02). ROC analysis demonstrated that the scale discriminated between patients and non-medicated controls, who scored differently for real side-effects but not for 'red herring' items. The LUNSERS is an efficient, reliable and valid method of assessing neuroleptic side-effects.
Medical subject headings
- Antipsychotic Agents
- Neurologic Examination
- Schizophrenia
- Schizophrenic Psychology